Biomol Ther.  2018 Nov;26(6):533-538. 10.4062/biomolther.2018.179.

Pathophysiological Role of S-Nitrosylation and Transnitrosylation Depending on S-Nitrosoglutathione Levels Regulated by S-Nitrosoglutathione Reductase

• Choi MS

• KMID: 2427505
• DOI: http://doi.org/10.4062/biomolther.2018.179

Abstract

Nitric oxide (NO) mediates various physiological and pathological processes, including cell proliferation, differentiation, and inflammation. Protein S-nitrosylation (SNO), a NO-mediated reversible protein modification, leads to changes in the activity and function of target proteins. Recent findings on protein-protein transnitrosylation reactions (transfer of an NO group from one protein to another) have unveiled the mechanism of NO modulation of specific signaling pathways. The intracellular level of S-nitrosoglutathione (GSNO), a major reactive NO species, is controlled by GSNO reductase (GSNOR), a major regulator of NO/SNO signaling. Increasing number of GSNOR-related studies have shown the important role that denitrosylation plays in cellular NO/SNO homeostasis and human pathophysiology. This review introduces recent evidence of GSNO-mediated NO/SNO signaling depending on GSNOR expression or activity. In addition, the applicability of GSNOR as a target for drug therapy will be discussed in this review.

Keyword

Nitric Oxide; S-nitrosylation; Transnitrosylation; GSNO; GSNOR

MeSH Terms

Cell Proliferation
Drug Therapy
Homeostasis
Humans
Inflammation
Nitric Oxide
Oxidoreductases*
Pathologic Processes
S-Nitrosoglutathione*
Nitric Oxide
Oxidoreductases
S-Nitrosoglutathione